Close
State Grid Zhenjiang Power Supply Company Enhances Real-time Estimation Accuracy for Low-voltage Distributed Photovoltaics Jun 3, 2024 01:34AM

ZHENJIANG, China, June 3, 2024 /PRNewswire/ -- Recently, the "Reference Station Assisted Selection Function" module, led by State Grid Zhenjiang Power Supply Company and developed by the State Grid Jiangsu Electric Power Research Institute, has been launched and implemented in the observable and measurable system for distributed photovoltaics in Jiangsu. Since then, the estimation accuracy for 26,000 low-voltage distributed photovoltaic users in one city and three... (continue reading...)


GenSight Biologics Appoints William Monteith to its Board of Directors Jun 3, 2024 01:30AM

PARIS--(BUSINESS WIRE)-- Regulatory News:

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the appointment of William Monteith to its Board of Directors. Mr. Monteith joined as an independent Director after existing Board members approved his... (continue reading...)


BW Energy: Fixed Income Investor Meetings Jun 3, 2024 01:30AM

BW Energy: Fixed Income Investor Meetings

BW Energy has engaged DNB Markets, a part of DNB Bank ASA and Pareto Securities AS as Joint Bookrunners to arrange a series of fixed income investor meetings. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue of USD 100 million with a tenor of five years may follow. The purpose of the bond issue is for general corporate purposes.

For further information, please contact:

... (continue reading...)


Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities) Jun 3, 2024 01:30AM

Press release

Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)

Meudon (France), June 3rd 2024 – Vallourec, a world leader in premium tubular solutions, announces the appointment of Andre Lacerda as Senior Vice President South America for the Tubes segment. In this capacity, he joins the Group's Executive Committee and will report to Bertrand Frischmann, Chief Operating Officer of the Americas.

Andre Lacerda has extensive... (continue reading...)


BGHL (GBP): NAV(s) Jun 3, 2024 01:30AM

                                      BOUSSARD & GAVAUDAN HOLDING LIMITED

Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

Close of business 31 May 2024.

Estimated NAV

  Euro Shares Sterling Shares Estimated NAV €    28.0156 £    25.1139 Estimated MTD return      1.19 %      1.29 % Estimated YTD... (continue reading...)

More Press Releases

View Older Stories

Jun 3, 2024 01:30AM BGHL (EUR): NAV(s)
Jun 3, 2024 01:30AM Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Jun 3, 2024 01:30AM Number of voting rights as of May 31, 2024
Jun 3, 2024 01:25AM Akastor ASA: HMH announces its intention to pursue US listing
Jun 3, 2024 01:25AM BW Energy: Appraisal confirms material Hibiscus field reserve increase
Jun 3, 2024 01:20AM Relief Therapeutics Announces Executive Changes
Jun 3, 2024 01:00AM Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
Jun 3, 2024 01:02AM Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
Jun 3, 2024 01:02AM Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
Jun 3, 2024 01:33AM Dreya Starr's Newest Releases!
Jun 3, 2024 01:30AM Pickleball Paradise hits the musical market
Jun 3, 2024 01:01AM Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
Jun 3, 2024 01:00AM New Kearney report: Chemicals M&A rebound expected in the next 12 to 18 months with return of sustainability goals, predict more than 50% of industry execs
Jun 3, 2024 01:00AM UAE TO HOST GAMES OF THE FUTURE 2025
Jun 3, 2024 01:00AM Start of Day Message
Jun 3, 2024 01:00AM Market Update
Jun 3, 2024 01:00AM New data with daridorexant to be presented at SLEEP 2024
Jun 3, 2024 01:00AM Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024
Jun 3, 2024 01:00AM ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
Jun 3, 2024 01:00AM Ipsen initiates a share buy-back program to cover its free employee share-allocation plan
Jun 3, 2024 01:00AM Ontex finalizes the divestment of its business in Pakistan
Jun 3, 2024 12:56AM Asia Green Fund U.S.-China Green Fund I Partner Conference 2023 is Successfully Held in Beijing
Jun 3, 2024 12:51AM Flash News: OKX to Support Mina Protocol's Upgrade
Jun 3, 2024 12:51AM Flash News: OKX to Support Mina Protocol's Upgrade
Jun 3, 2024 12:41AM Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
Jun 3, 2024 12:35AM Upcoming Acer Swift Series Laptops to Feature Models with New AMD Ryzen AI 300 Series Processors
Jun 3, 2024 12:15AM ASHTON-DRAKE RELEASES PREMIUM "RUDOLPH THE RED-NOSED REINDEER®" MASTERPIECE FIGURE COLLECTION
Jun 3, 2024 12:04AM HO CHI MINH CITY RIVER FESTIVAL EXPANDS IN SCALE, IGNITING SUMMER TOURISM IN 2024
Jun 3, 2024 12:02AM NetAlly Unveils Next Generation LinkRunner® AT Network and Cable Testers
Jun 3, 2024 12:01AM Private equity finds a footing but still searching for momentum as two-year slump bottoms out--Bain & Company's PE Midyear Report
Jun 3, 2024 12:01AM Triumph Motorcycle Dealers Ranked First in Industry Study for Providing Quick and Easy Service Appointments
Jun 3, 2024 12:00AM Sigma 28-45mm F1.8 Full Frame DG DN Art Lens Announced; YouTube Video First Look, Learn More Info at B&H Photo Video
Jun 3, 2024 12:00AM ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
Jun 3, 2024 12:00AM 10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours
Jun 3, 2024 12:00AM IXOPAY Appoints Brady Harris as CEO to Drive Global Payments Growth
Jun 3, 2024 12:00AM BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
Jun 2, 2024 11:35PM MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
Jun 2, 2024 11:30PM The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
Jun 2, 2024 11:01PM AMD Unveils Next-Gen “Zen 5” Ryzen Processors to Power Advanced AI Experiences
Jun 2, 2024 11:00PM AMD Accelerates Pace of Data Center AI Innovation and Leadership with Expanded AMD Instinct GPU Roadmap
Jun 2, 2024 10:59PM AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen and EPYC Processors at Computex 2024
Jun 2, 2024 10:57PM Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
Jun 2, 2024 10:51PM Appointment of Director to Woodside Board
Jun 2, 2024 10:28PM NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 2, 2024 10:15PM 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
Jun 2, 2024 10:13PM Flash News: OKX Launches 100% Fee Rebate Campaign
Jun 2, 2024 10:00PM Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
Jun 2, 2024 10:00PM LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
Jun 2, 2024 09:41PM Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
Jun 2, 2024 09:30PM Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
View Older Stories